Cornerstone Therapeutics Inc. (NASDAQ:CRTX)
CAPS Rating:
A biopharmaceutical company focused on the development and commercialization of products designed to treat respiratory, inflammatory and critical care diseases linked to the body's inflammatory response.
RSS Headlines
Fool UK
Recs
If you really look indepth into this company then you would know it is poised to explode. Great forward P/E, P/S, P/Book while holding alot of cash with very little debt. 72.5% insider owned while still trading under 200M volume... Tom Gardner knows it and so should you. JUMP IN NOW!